- Previous Close
1,283.70 - Open
1,292.20 - Bid --
- Ask --
- Day's Range
1,278.55 - 1,306.25 - 52 Week Range
1,243.00 - 1,690.00 - Volume
145,864 - Avg. Volume
161,677 - Market Cap (intraday)
136.464B - Beta (5Y Monthly) -0.08
- PE Ratio (TTM)
52.91 - EPS (TTM)
24.27 - Earnings Date --
- Forward Dividend & Yield 5.00 (0.39%)
- Ex-Dividend Date Aug 29, 2024
- 1y Target Est
1,547.40
Clean Science and Technology Limited, research, develops, manufactures, and markets specialty chemicals in India and internationally. The company operates through Performance Chemicals, FMCG Chemicals, and Pharma & Agro Intermediates segments. It also offers FMCG Chemicals, including anisole, guaiacol, 4-methoxy acetophenone, butylated hydroxy anisole, veratrole, L-ascorbyl palmitate, tertiary butyl hydroquinone, ortho methoxy toluene, and para di-methoxy benzene (1,4-DMB). In addition, the company offers performance chemicals comprising clean light stab 770, 4-hydroxy tempo, mono methyl ether of hydroquinone, butylated hydroxy anisole, L-ascorbyl palmitate, 2,5-di-tertiary butyl hydroquinone, tertiary butyl hydroquinone, and dimethyl sebacate. Further, it provides pharma and agro intermediates, such as dicyclohexylcarbodimide, veratrole, para benzoquinone, and para di-methoxy benzene (1,4-DMB). Clean Science and Technology Limited serves food and infant food formulations, agricultural chemicals, polymers and monomers, perfumes, cosmetic, and other sectors. The company was incorporated in 2003 and is based in Pune, India.
www.cleanscience.co.in457
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: CLEAN.NS
View MorePerformance Overview: CLEAN.NS
Trailing total returns as of 11/29/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CLEAN.NS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CLEAN.NS
View MoreValuation Measures
Market Cap
136.38B
Enterprise Value
133.06B
Trailing P/E
53.00
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
15.64
Price/Book (mrq)
10.52
Enterprise Value/Revenue
15.25
Enterprise Value/EBITDA
32.59
Financial Highlights
Profitability and Income Statement
Profit Margin
29.12%
Return on Assets (ttm)
14.10%
Return on Equity (ttm)
21.57%
Revenue (ttm)
8.84B
Net Income Avi to Common (ttm)
2.58B
Diluted EPS (ttm)
24.27
Balance Sheet and Cash Flow
Total Cash (mrq)
3.34B
Total Debt/Equity (mrq)
0.16%
Levered Free Cash Flow (ttm)
1.5M